ImExHS Limited (ASX:IME)
Australia · Delayed Price · Currency is AUD 0.3050
-0.0250 (-7.58%)
Oct 15, 2026, 2:50 PM AEST
ImExHS Market Cap
ImExHS has a market cap or net worth of 16.59 million as of October 15, 2026. It is the 40,766th most valuable company in the world and the 1,148th biggest in Australia. Its market cap has increased by 23.08% in one year.
Market Cap
16.59M
Enterprise Value
15.06M
Revenue
31.27M
Global Rank
Country Rank
#1,148 Australia
PE Ratio
88.10
ChartMarket Cap Chart
Since September 3, 2018, ImExHS's market cap has decreased from 24.99M to 16.59M, a decrease of -33.62%. That is a compound annual growth rate of -4.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 16.59M | -23.26% |
| Dec 30, 2025 | 21.62M | 25.63% |
| Dec 31, 2024 | 17.21M | -39.72% |
| Dec 29, 2023 | 28.55M | 50.42% |
| Dec 30, 2022 | 18.98M | -44.20% |
| Dec 31, 2021 | 34.01M | -28.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 3, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 532.93M |
| Monash IVF Group | 280.54M |
| Healius | 270.49M |
| Cryosite | 58.82M |
| Microba Life Sciences | 29.41M |
| BCAL Diagnostics | 29.13M |
| Rhythm Biosciences | 24.42M |
| INOVIQ | 19.00M |